Could Novel Therapies Redefine Outcomes in the Hormone-Refractory...

σε πρόσθεσε στο Networking

2026-06-23 05:19:05 - Μετάφραση -

Could Novel Therapies Redefine Outcomes in the Hormone-Refractory Oncology Drug Market?

According to the latest report published by Data Bridge Market Research, the Hormone-Refractory Oncology Drug Market CAGR Value The global hormone-refractory oncology drug market size was valued at USD 5.33 billion in 2025 and is expected to reach USD 12.46 billion by 2033, at a CAGR of 11.20% during the forecast period The Hormone-Refractory Oncology Drug Market report not...

0 Σχόλια 0 Μοιράστηκε 43 Views 0 Προεπισκόπηση